fda food and drug administration news

FDA approves a new type of schizophrenia drug

FDA approves first new drug for schizophrenia in more than 30 years

The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with schizophrenia in more than 30 years. Cobenfy, manufactured by Bristol Myers

Sierra Sun Times · 1h

FDA Approves Drug with New Mechanism of Action for Treatment of Schizophrenia

Schizophrenia can cause psychotic symptoms including hallucinations (such as hearing voices), difficulty controlling one’s thoughts and being suspicious of others. It can also be associated with cognitive problems and difficulty with social interactions and motivation.

AOL · 8h

This FDA-approved drug promises a new way to treat schizophrenia

Bristol Myers Squibb's drug, KarXT, improved symptoms of adults with schizophrenia and had fewer side effects than antipsychotic treatments

FDA issues recall notices over 2 brands of pet food

YAHOO!News · 19h

FDA issues recall notices for two brands of pet food over salmonella and listeria contamination

Pet owners are advised to throw away the at-risk products safely, so pets and children can't access and ingest them

AOL · 1d

These 2 brands of pet food may be contaminated with salmonella and listeria, FDA says

The U.S. FDA issued warnings for ANSWERS Pet Food and Darwin's Natural Pet Products as they contain Salmonella and Listeria. Biggest risk is passing it on to humans.

NBC New York · 21h

FDA issues recall notices over 2 brands of pet food due to salmonella and listeria risk

Answers Pet Food and Darwin’s Natural Pet Products, were found to have produced pet food that was contaminated with the bacteria salmonella and listeria, which can cause illness in pets that can then infect their owners.

FDA Lifts Clinical Hold On BMF-219

Reuters on MSN · 20h

US FDA lifts clinical hold on Biomea's diabetes trials

Biomea Fusion said on Thursday the U.S. Food and Drug Administration lifted a clinical hold on ongoing studies of its experimental drug for type 1 and 2 diabetes, sending its shares up 6.9%. The decision comes as a boon for the company as the regulator placed a hold on two trials of its lead drug,

Business Insider · 19h

FDA Lifts Clinical Hold on BMF-219 in Type 2 and Type 1 Diabetes Trials

We greatly appreciate FDA’s review of our data, and the swift resolution of the clinical trial hold. The in-depth review of the clinical data to date reconfirms our confidence in BMF-219 as a novel, first-in-class agent for the treatment of diabetes.

MarketWatch · 21h

Biomea Fusion: FDA Lifts Hold on Diabetes-Treatment Trials

Biomea Fusion said the Food and Drug Administration lifted its clinical hold on continuing clinical trials of the company's diabetes drug. The FDA in June put the biopharmaceutical company's trials on hold,

14h

FDA approves new schizophrenia drug

The U.S. Food and Drug Administration has approved a new drug for adults with schizophrenia, the FDA announced Thursday.

FDA Approves New Schizophrenia Drug in 70-Year First

The treatment offers hope to thousands of patients who do not respond to existing medications, and has shown promise in treating other neurological disorders.

Neurology Advisor1h

FDA Approves Self-Administration of Influenza Vaccine FluMist

The FDA has approved at-home self- or caregiver-administration of FluMist (influenza vaccine live, intranasal).

Investopedia17d

Food and Drug Administration (FDA): What It Is and Does

Her expertise is in personal finance and investing, and real estate. The Food and Drug Administration (FDA) is a government agency that is responsible for the promotion and protection of public ...

1hon MSN

US FDA approves Sanofi-Regeneron's Dupixent for 'smoker's lung'

The U.S. Food and Drug Administration has approved Sanofi and Regeneron's blockbuster drug Dupixent for patients with a ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results